Related Experiment Video
Updated: Mar 18, 2026
06:24
Minimal Erythema Dose MED Testing
Published on: May 28, 2013
43.1K
Lichenoid drug eruption induced by colchicine: case report
Isa An1, Vasfiye Demir2, Sedat Akdeniz1
1a Department of Dermatology and.
Cutaneous and Ocular Toxicology
|June 28, 2016
Summary
Colchicine treatment can cause lichenoid drug eruptions (LDE), a rare skin reaction. This case study documents LDE appearing on the abdomen and legs during colchicine therapy, highlighting a potential adverse effect.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Lichenoid drug eruption (LDE) is a known cutaneous adverse effect associated with various medications.
- The specific link between colchicine and LDE is poorly understood and infrequently reported in medical literature.
Observation:
- A patient undergoing colchicine treatment developed a distinct skin reaction.
- The eruption manifested as lichenoid lesions predominantly on the abdomen and lower extremities.
Findings:
- The case presents a documented instance of LDE occurring during colchicine therapy.
- This observation adds to the limited existing evidence of colchicine-induced LDE.
Implications:
- Clinicians should consider LDE in patients presenting with characteristic skin lesions while on colchicine.
- Further research is warranted to elucidate the physiopathologic mechanisms underlying colchicine-induced LDE.
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
131
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
131
01:30Drug Toxicity: Allergic Reactions
106
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
106
01:27Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
596
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
596
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
602
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
602
01:24Drug Toxicity: Risk factors
113
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
113